Pharmaceutical stocks are making headlines today, after two U.S.-based sector heavyweights stepped into the earnings confessional this morning and last night. Options traders are reacting accordingly.AbbVie Inc (NYSE:ABBV) is up 1.1% to trade at $182.53, after the company reported adjusted first-quarter earnings of$2.46 per share on $13.3 billion in revenue, both of which exceeded analyst expectations. AbbVie also raised its full-year outlook, expecting its flagship psoriasis drug Skyrizi to take in$16.5 ...